Although there are commercial direct and indirect assays for HPV-related head and neck squamous cell carcinoma, none are ideal.
尽管有不少商业化方案可以直接或间接检测HPV相关的头颈部肿瘤，但是都不太理想。
The infiltration of DC with different phenotype in head and neck squamous cell carcinoma(HNSCC) patients correlates to tumor prognosis closely.
头颈鳞状细胞癌（HNSCC）局部不同表型的DC浸润与肿瘤预后密切相关。
This paper aims to observe the short term efficiency and safety of Cetuximab combined with radiotherapy of head and neck squamous Cell carcinoma in Chinese patients.
本文旨在观察西妥昔单抗联合放疗对中国局部晚期头颈部鳞癌患者的近期疗效和安全性。
应用推荐